The Sacred Knowledge of Psychedelic States: A Conversation with Dr. Bill Richards

Psychedelics have been making waves in the world of mental health, offering hope for people struggling with depression, PTSD, and even end-of-life anxiety. But how did we get here, and what does the research actually show? In a recent webinar, Dr. Bill Richards, a pioneer in the field, sat down with Dr. Houman Farzin to discuss the evolution of psychedelic research, psychedelic therapy, the role of music in psychedelic experiences, and what the future might hold. Here’s what we learned.

A note before we begin: psilocybin, LSD, and MDMA are investigational in the United States. They are not approved treatments and are available only within approved research studies. Mystic does not offer them. This conversation is about the history and science of that research.

The Evolution of Psychedelic Research

Dr. Richards has been studying psychedelics for over 50 years, starting in the 1960s, when the public’s perception was very different from what it is now. Back then, psychedelics weren’t controversial, and researchers were able to openly explore their effects. “It was the most natural thing for a psychiatrist to receive psilocybin or LSD in the mail from Sandoz and just give it to patients to see what happened,” he recalled. Research was largely halted from the 1970s onward, and only in recent decades has it returned. Today, many clinical trials are under way, and psychedelics have become a serious topic in mental health research.

As we dove deeper into the conversation, they discussed psychedelic-assisted therapy, an approach being studied that pairs a psychedelic with psychotherapy in the hope of creating longer-lasting change. Dr. Houman, a palliative care physician with training in emerging mental health therapies, reflected on how this research could change healthcare. “I personally see a future where we can prevent disease by being able to apply these therapies earlier, and addressing trauma and helping people live better lives,” he said. It’s not just about healing, it's about whole-person transformation.

The Power of Set, Setting, and Support

One of the most important lessons Dr. Richards learned from the early days of psychedelic research is that the environment where psychedelic journeys are taking place matters, a lot. In some instances in the 60s, people were just given a psychedelic and left alone in a basement room. That led to unpredictable and sometimes distressing experiences. Researchers now more fully understand the importance of “set and setting”: a person’s mindset and the physical and social environment of the session.

After switching to rooms with light and plants, Dr. Richards noted how, “All of a sudden, those high dosage experiences were beautiful and transcendental and meaningful, instead of crazy and frightening.” Dr. Richards also emphasized the benefit of someone being present with the participant throughout their journey noting,
“The safe, effective use of these facilitators of exploring consciousness [psychedelics], requires interpersonal grounding.” In today’s clinical trials, that means trained facilitators, careful screening, and a safe, supervised environment.

Elements of the Psychedelic Experience

A big part of the discussion revolved around the deep, mystical experiences that psychedelics can trigger. Dr. Richards explained that these states feel “intuitively more real or more fundamental than our everyday awareness.” They bring feelings of interconnectedness and profound insights about life and death. For some, this can be spiritual; for others, it’s simply an eye-opening realization about existence.

Music can play a large role in these journeys. Dr. Richards believes that music can act as a guide, "Structured sound [music], if well chosen, with appropriate dosage and timing, can significantly deepen the states of consciousness experienced, and can also ensure the safety of the inner journey.” It is important to note that the music used must be thoughtfully prepared. Dr. Richards explained that when appropriate music is chosen, the “Music does not cause the content of an experience, but the structure of the sound can enable one to move through potentially changing material, and to, as we say, trust, let go, and be open."

Dr. Houman, who is passionate about music’s role in healing, emphasized its power in creating a safe and immersive experience. “[Music] is like a therapist or sitter in the room,” he said. Music has the potential to hold space, guide emotions, and help process deep feelings that words alone can’t reach. He also noted that different genres and styles can be used depending on the individual. From classical compositions to birdsong, music is chosen carefully in research and clinical settings.

Another fascinating topic was the use of mandalas in psychedelic therapy. Mandalas are unique geometric patterns that can symbolize wholeness, spirituality, and/or a journey toward self-discovery. They are unique to each individual, often revealing deep reflections of the inner state through the patterns and colors used. Dr. Richards’ team at Spring Grove and the Maryland Psychiatric Research Center found that patients' mandalas, created before and after their sessions, revealed deep personal insights. “It was amazing, I mean, someone untrained in art therapy would recognize the struggle and conflict of early mandalas, and the clarity, affirmation, and strength of the latter mandalas,” Dr. Richards noted.

Mandalas can also be useful in preparation for a psychedelic therapy session, “It’s a good thing to do in preparation…to share your associations with your therapist… it’s a nonverbal way of communicating content,” Dr. Richards said.

Looking into the Future of Psychedelics

Despite all the excitement, both experts stressed the importance of responsible research and care. Dr. Richards imagines a future where psychedelics are simply another tool in healthcare, particularly in palliative care. “The benefit could be immense. Imagine if we really approach death differently in Western culture. There is so much psychological distress that’s fueled by unresolved grief and the trauma of people dying without reconciliation and forgiveness and insight. We can do something about that.”

Dr. Houman also touched on concerns about commercialization. With these “potentially sacred chemicals,” ensuring caring, compassionate, and responsible distribution is important for maintaining their availability to help people on their healing journey.

Beyond palliative care, the possibilities for psychedelics are expanding rapidly. Research is exploring their role in treating addiction, eating disorders, and even enhancing creativity. Dr. Houman envisions a time when these substances are integrated into preventative mental health care. However, both experts agreed that as psychedelics become more mainstream, there’s a need for clear ethical guidelines, proper training for facilitators, and protections against misuse.

The webinar was packed with wisdom, personal experiences, and a vision for the future of psychedelics. Both Dr. Richards and Dr. Houman believe that these substances, if research continues to support them and they are given responsibly in clinical settings, could help many people. As Dr. Richards put it, “I'm profoundly impressed at the rapidity of healing and personality development that can occur with the responsible use of psychedelics.” Research on psychedelics is likely to keep growing, and so does the need for clear, accurate public education about what is and is not known. For now, outside of research studies, the medicines of this kind available in US clinical care are ketamine, prescribed off-label, and esketamine (Spravato), which is FDA-approved for treatment-resistant depression. At Mystic, that means ketamine-assisted psychotherapy and Spravato, both given with medical screening and monitoring.